Carcinogenesis, Vol. 22, No. 11, 1877-1883,
November 2001
© 2001 Oxford University Press
CARCINOGENESIS |
Rat oesophageal cytochrome P450 (CYP) monooxygenase system: comparison to the liver and relevance in N-nitrosodiethylamine carcinogenesis
Departamento de Bioquímica, IBRAG, Universidade do Estado do Rio de Janeiro, Av. 28 de Setembro, 87, fundos, 4° andar, Vila Isabel, Rio de Janeiro, RJ, Brasil and
1 Department of Pharmaceutical Biosciences, Division of Biochemistry, Uppsala University, Uppsala, Sweden
N-nitrosodiethylamine (NDEA) is able to induce tumours in the rat oesophagus. It has been suggested that this could be due to tissue specific expression of NDEA activating cytochrome P450 enzymes. We investigated this by characterizing the oesophageal monooxygenase complex of male Wistar rats and comparing it with that of the liver. Total amount of cytochrome P450, NADPH P450 reductase, cytochrome b5 and cytochrome b5 reductase of the oesophageal mucosa was ~7% of what was found in the liver. In addition, major differences were found in the cytochrome P450 isoenzyme composition between these organs: CYP 2B1/2B2 and CYP3A were found only in the liver, whereas CYP1A1 was constitutively expressed only in the oesophagus. Of the two well-known nitrosamine metabolizing enzymes, CYP2A3 was found only in the oesophagus whereas CYP2E1 was exclusively expressed in the liver. Catalytic studies, western blotting and RT–PCR analyses confirmed the expression of CYP2A3 in the oesophagus. CYP2A enzymes are known to be good catalysts of NDEA metabolism. Oesophageal microsomes had a Km for NDEA metabolism, which was about one-third of that of hepatic microsomes, but they showed similar activities when compared per nmol of total P450. NDEA activity in the oesophagus was significantly increased by coumarin (CO), which also induced oesophageal CYP2A3. Immunoinhibition of the microsomal NDEA activity showed that up to 70% of this reaction is catalysed by CYP2A3 in the oesophagus, whereas no inhibition of the hepatic NDEA activity could be achieved by the anti-CYP2A5 antibody. NDEA, but not N-nitrosodimethylamine (NDMA) inhibited the oesophageal metabolism of CO. The results of the present investigation show major differences in the enzyme composition of the oesophageal and hepatic monooxygenase complexes, and are in accordance with the hypothesis that the NDEA organotropism could, to a large extent, be due to the tissue specific expression of the activating enzymes.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Rossini, D.C.M. Rapozo, S.C. Soares Lima, D.P. Guimaraes, M.A. Ferreira, R. Teixeira, C.D.P. Kruel, S.G.S. Barros, N.A. Andreollo, R. Acatauassu, et al. Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population Carcinogenesis, December 1, 2007; 28(12): 2537 - 2542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Reen, A. A. Dombkowski, L. A. Kresty, D. Cukovic, J. M. Mele, S. Salagrama, R. Nines, and G. D. Stoner Effects of Phenylethyl Isothiocyanate on Early Molecular Events in N-Nitrosomethylbenzylamine-Induced Cytotoxicity in Rat Esophagus Cancer Res., July 1, 2007; 67(13): 6484 - 6492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Tyden, H. Tjalve, and P. Larsson Metabolic Activation of 2,6-Xylidine in the Nasal Olfactory Mucosa and the Mucosa of the Upper Alimentary and Respiratory Tracts in Rats Toxicol. Sci., October 1, 2004; 81(2): 263 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Finnberg, I. Silins, U. Stenius, and J. Hogberg Characterizing the role of MDM2 in diethylnitrosamine induced acute liver damage and development of pre-neoplastic lesions Carcinogenesis, January 1, 2004; 25(1): 113 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Piras, A. Franzen, E. L. Fernandez, U. Bergstrom, F. Raffalli-Mathieu, M. Lang, and E. B. Brittebo Cell-specific Expression of CYP2A5 in the Mouse Respiratory Tract: Effects of Olfactory Toxicants J. Histochem. Cytochem., November 1, 2003; 51(11): 1545 - 1555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Montero, L. Serrano, V. M. Davila, A. Ito, and A. Plancarte Infection of rats with Taenia taeniformis metacestodes increases hepatic CYP450, induces the activity of CYP1A1, CYP2B1 and COH isoforms and increases the genotoxicity of the procarcinogens benzo[a]pyrene, cyclophosphamide and aflatoxin B1 Mutagenesis, March 1, 2003; 18(2): 211 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Wong, S. E. Murphy, M. Wang, and S. S. Hecht Comparative metabolism of N-nitrosopiperidine and N-nitrosopyrrolidine by rat liver and esophageal microsomes and cytochrome P450 2A3 Carcinogenesis, February 1, 2003; 24(2): 291 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Godoy, R. M. Albano, E. G. Moraes, P. R. A. Pinho, R. A. Nunes, E. H. Saito, C. Higa, I. M. Filho, C. D. P. Kruel, C. C. Schirmer, et al. CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism Carcinogenesis, April 1, 2002; 23(4): 611 - 616. [Abstract] [Full Text] [PDF]
|
|